Related Experiment Video
Updated: Jul 5, 2026

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017
Probability of ten-year survival in metastatic renal cell carcinoma
Maciej Salagierski1, Marek Salagierski, Anna Salagierska-Barwińska
12nd Department of Urology, Medical University of Łódź, Łódź, Poland. msalagierski@yahoo.com
Abstract:
Metastatic renal cancer has a very poor prognosis and constitutes a challenge to uro-oncologists. We present a patient who in the 10 years following the diagnosis of renal cell carcinoma developed nine consecutive metastases in as many sites. He was operated on eleven times in different departments and received systemic therapy. We performed two percutaneous radiofrequency ablations of the cancer mass in the remaining kidney, which gave him the possibility of preserving renal function and we used the ablation technique to coagulate the metastatic mass in the psoas muscle. Furthermore, we executed an adrenalectomy and removed the ablated kidney tumor. The patient's long-term survival, as well as the various applications of radiofrequency ablation, would seem to be worth reporting.
More Related Videos
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Survival Analysis

